AVANT to Report Second Quarter Fiscal 2007 Financial Results on August 2, 2007.- Conference Call to Follow - NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) will release its second quarter and six-month fiscal 2007 financial results before U.S. financial markets open on August 2, 2007. AVANT Immunotherapeutics, Inc. CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Una S. Ryan, and CFO See Chief Financial Officer. , Avery (Chip) W. Catlin, will host a conference call and live audio webcast at 11:00 am ET that same day. To access the conference call, dial 800-659-2037 (within the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. ), or 617-614-2713 (if calling from outside the U.S.). The passcode for participants is 74142034. An audio replay will be available approximately two hours after the call for approximately one week and can be accessed by dialing 888-286-8010 (within the U.S.), or 617-801-6888 (if calling from outside the U.S.). The passcode I.D. number is 67559598. The replay will also be broadcast via the Company's website www.avantimmune.com approximately two hours after the live call. Additionally, a copy of this press release is available by contacting Investor Relations Investor relations The process by which the corporation communicates with its investors. at (781) 433-0771. About AVANT Immunotherapeutics, Inc. AVANT Immunotherapeutics, Inc. discovers and develops innovative vaccines and therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. that harness the human immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. to prevent and treat disease. AVANT has three products on the market and four of AVANT's products are in clinical development. AVANT's pipeline includes products for travelers' vaccines and global health needs based on AVANT's oral, rapid-protecting, single-dose and temperature stable vaccine technology. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion